IDG Home | IDG
SGC - Home
Description: Medicines for all, Target 2035 aims to develop a pharmacological modulator for every protein in the human proteome.
medicines (297) target 2035 (1)
PFI-653 and its negative control can be used to explore the role of VNN-1 in inflammatory and other diseases
[email protected] v3.24.1.9 About Contact Phases Login Read more Upcoming webinar Archived Recordings Links Privacy policy Target 2035 All rights reserved
The Tareget 2035 initative is supported by EUbOPEN. The EUbOPEN project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 875510. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme, EFPIA companies and Associated Partners: KTH, OICR, Diamond and McGill. This communication reflects the views of the authors and neither IMI nor the European Union, EFPIA or any Associated Partners are liable fo
IDG Home | IDG
SGC - Home